Search for: "Courtenay Brinckerhoff"
Results 21 - 40
of 92
Sorted by Relevance
|
Sort by Date
14 Jun 2013, 9:15 pm
Brinckerhoff and hosted by... [read post]
27 Feb 2015, 7:23 pm
Courtenay Brinckerhoff of Foley & Lardner; Matthew Dowd of Wiley Rein, LLP; and Mary Till, USPTO Office of Patent Legal Administration will cover evidentiary declarations under the First Inventor to File (FITF) system, including declarations relating to the 1-year grace period under the new section 102(b), explain Rule 132 declarations and other evidence to overcome obviousness rejections, and demonstrate how to avoid common pitfalls that can... [read post]
5 Aug 2018, 9:52 pm
Courtenay Brinckerhoff of Foley & Lardner LLP, Charles Chesney of Qualcomm Inc., and Roland McAndrews of Bookoff McAndrews PLLC will discuss potential pitfalls associated with U.S. provisional or CIP patent applications. [read post]
14 Nov 2011, 1:00 am
The following analysis of the changes to 35 USC § 102 under the America Invents Act comes from Courtenay Brinckerhoff ,writer of PharmaPatents Blog and Partner at Foley & Lardner. [read post]
14 Nov 2011, 1:00 am
The following analysis of the changes to 35 USC § 102 under the America Invents Act comes from Courtenay Brinckerhoff ,writer of PharmaPatents Blog and Partner at Foley & Lardner. [read post]
10 Aug 2012, 5:30 pm
Also in today’s roundup: Al Saikali breaking down the FTC’s $22.5 million fine against Google and Courtenay Brinckerhoff continuing her superb commentary on the America Invents Act. [read post]
26 Jan 2019, 8:38 pm
Paul Hunter, Courtenay Brinckerhoff, and Daniel Rose of Foley & Lardner LLP discuss best practices for preparation and prosecution in view of the 2019 Revised Patent Subject Matter Eligibility Guidance, and address the following topics: • Key Takeaways and Evaluating the 2019 Revised Patent Subject Matter Eligibility Guidance • Section 101—Understanding Steps 2A and 2B • Prosecution Strategies for Obtaining Valuable Patents Under New Guidance •… [read post]
20 Oct 2011, 2:00 am
The following analysis of the new 35 USC § 102(a)(2) provision in the Leahy-Smith America Invents Act eliminating the Hilmer doctrine and giving prior art effect to U.S. patent applications as of their foreign filing dates comes from Courtenay Brinckerhoff ,writer of PharmaPatents Blog and Partner at Foley & Lardner. [read post]
20 Oct 2011, 2:00 am
The following analysis of the new 35 USC § 102(a)(2) provision in the Leahy-Smith America Invents Act eliminating the Hilmer doctrine and giving prior art effect to U.S. patent applications as of their foreign filing dates comes from Courtenay Brinckerhoff ,writer of PharmaPatents Blog and Partner at Foley & Lardner. [read post]
22 Jun 2009, 12:49 am
" The participants included Foley & Lardner attorneys Jonathan Spivey, Jon Dudas, Courtenay Brinckerhoff, and Sharon Barner, along with IBM's David Kappos, now indicated to be the nominee of Barack Obama for undersecretary at Commerce and Director of the USPTO. [read post]
28 Mar 2021, 6:00 pm
Courtenay C. [read post]
1 Dec 2011, 5:38 pm
Instead, we have an interesting story coming out of Massachusetts from Donald Pinto and Courtney Brinckerhoff continues to do a good job tracking developments at the US Patent and Trademark Office. [read post]
2 Aug 2011, 8:02 am
Brinckerhoff and Jacqueline D. [read post]
2 Aug 2011, 8:02 am
Brinckerhoff and Jacqueline D. [read post]
24 Mar 2011, 2:35 am
Of late, Editor Courtenay Brinckerhoff has been discussing patent reform, human antibody claims, license agreements, and "definiteness. [read post]
4 Apr 2011, 8:36 pm
Or, as attorney Courtenay Brinckerhoff, a partner with the law firm Foley and Lardner, posed the question in a statement: "Can Myriad explain the difference between patenting isolated DNA and patenting a leaf that has fallen off of a tree? [read post]
2 Oct 2009, 8:21 am
" See Jon Dudas to Foley & Lardner DC office See also the IPBiz posts: Kappos and IBM in May 2009 discussing a panel including Foley & Lardner attorneys Jonathan Spivey, Jon Dudas, Courtenay Brinckerhoff, and Sharon Barner, along with IBM's David Kappos (now USPTO director)IP-Watch on Obama IP insiders [read post]
16 Aug 2012, 7:06 pm
Read Foley & Lardner’s review and analysis here and Courtenay Brinckerhoff’s PharmaPatents post. [read post]
20 Dec 2010, 11:48 am
Brinckerhoff and Antoinette F. [read post]
20 Dec 2010, 11:48 am
Brinckerhoff and Antoinette F. [read post]
